The Wellcome Trust Sanger Institute responds to the Chief Medical Officer's annual report 2016: Generation Genome

The UK Chief Medical Officer's report has highlighted the key role genomics and genetics will play in future healthcare provision. Associate director Dr Julia Wilson and honorary faculty member Professor Sharon Peacock comment

The Wellcome Trust Sanger Institute responds to the Chief Medical Officer's annual report 2016: Generation Genome

Professor Dame Sally Davies's eighth independent report to government as CMO - Generation Genome - looks at how genomics can improve health and prevent ill-health.

Below Dr Julia Wilson gives the Wellcome Trust Sanger Institute's response, and in a related post on our blog site Professor Sharon Peacock outlines how using genomics is changing the way infectious disease outbreaks are identified, treated and controlled.

picture-jw20.jpgGenome Research Limited
Julia Wilson, associate director at the Wellcome Trust Sanger Institute

“The Wellcome Trust Sanger Institute welcomes the Chief Medical Officer’s report that acknowledges the central role of genomics in improving future healthcare. From the beginning, the Sanger Institute has been instrumental in powering the genomic revolution. Medical treatments and diagnoses have been transformed by genomics and genetic research in conditions as diverse as inherited diseases, infections and cancer. This will continue as we reveal further the secrets of genomes which will drive the development of personalised medicine in the UK.”

Dr Julia Wilson, associate director of the Wellcome Trust Sanger Institute

How genomics is transforming infectious disease
sharonpeacock.jpg
Professor Sharon Peacock is an honorary faculty member at the Sanger Institute

The UK Chief Medical Officer's annual report 2016: Generation Genome has highlighted the vital role genetics and genomics will play in UK NHS healthcare and medicine. Professor Sharon Peacock helped write the report's chapter on Infectious disease and has written a blog outlining how genomics is set to transform how doctors diagnose and treat outbreaks.

Blog: Chief Medical Officer’s fifth annual report (advocacy volume) on genomics highlights the potential for pathogen genomics in patient diagnosis and infection control

Notes to Editors
Publication:

Chief Medical Officer annual report 2016: Generation Genome
Professor Dame Sally Davies’s eighth independent report to government as CMO looks at how genomics can improve health and prevent ill-health.

Selected Websites
Personal genomics: the future of healthcare?StoriesPersonal genomics: the future of healthcare?
Personal genomics is an area of genomics focusing specifically on the sequencing and analysis of one person’s genome, and then giving them their genomic information.

What is pharmacogenomics?FactsWhat is pharmacogenomics?
Pharmacogenomics is the tailoring of drug treatments to people’s genetic makeup, a form of ‘personalised medicine’.

Genome-wide association studiesStoriesGenome-wide association studies
Genome-wide association studies have led to the discovery of hundreds of genes with a role in common diseases.

Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Genome damage from CRISPR/Cas9 gene editing higher than thought

Caution required for using CRISPR/Cas9 in potential gene therapies

Roots of leukaemia reveal possibility of predicting people at risk

Mutations in blood identify individuals at high risk of developing leukaemia

Cholera spread tracked at household level

The results could be used by public health officials to improve cholera control strategies